Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06854952 | A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity | PHASE2 | COMPLETED | 167 | — | — | Mar 1, 2025 | Sep 1, 2025 | Nov 5, 2025 | - | — |
| Name | Type | Description |
|---|---|---|
| TERN-601 | DRUG | Investigational drug |
| Matching Placebo | OTHER | Matching placebo |